Investors bought shares of Monsanto (NYSE:MON) on weakness during trading on Tuesday. $95.36 million flowed into the stock on the tick-up and $39.53 million flowed out of the stock on the tick-down, for a money net flow of $55.83 million into the stock. Of all stocks tracked, Monsanto had the 29th highest net in-flow for the day. Monsanto traded down ($0.48) for the day and closed at $120.31
A number of equities analysts recently commented on the stock. Wells Fargo & Co reiterated a “market perform” rating and set a $128.00 target price (up previously from $118.00) on shares of Monsanto in a research note on Wednesday, January 17th. Deutsche Bank reiterated a “buy” rating on shares of Monsanto in a research note on Tuesday, January 16th. Zacks Investment Research downgraded shares of Monsanto from a “buy” rating to a “hold” rating in a research note on Monday, December 11th. Finally, Royal Bank of Canada reiterated a “hold” rating and set a $128.00 target price on shares of Monsanto in a research note on Wednesday, November 15th. Eleven research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of $127.30.
The company has a current ratio of 1.28, a quick ratio of 0.79 and a debt-to-equity ratio of 1.05. The firm has a market cap of $53,030.00, a P/E ratio of 22.24, a PEG ratio of 1.73 and a beta of 1.01.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Friday, April 6th will be paid a $0.54 dividend. The ex-dividend date of this dividend is Thursday, April 5th. This represents a $2.16 annualized dividend and a yield of 1.80%. Monsanto’s dividend payout ratio is presently 39.93%.
In other Monsanto news, EVP Steven Mizell sold 8,100 shares of the company’s stock in a transaction on Tuesday, January 9th. The shares were sold at an average price of $119.35, for a total value of $966,735.00. Following the completion of the transaction, the executive vice president now owns 56,743 shares in the company, valued at $6,772,277.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.70% of the company’s stock.
Several large investors have recently made changes to their positions in MON. Gradient Investments LLC purchased a new stake in shares of Monsanto in the fourth quarter valued at about $108,000. Americafirst Capital Management LLC purchased a new stake in shares of Monsanto in the third quarter valued at about $148,000. Tyers Asset Management LLC raised its holdings in shares of Monsanto by 90.9% in the fourth quarter. Tyers Asset Management LLC now owns 1,386 shares of the basic materials company’s stock valued at $162,000 after buying an additional 660 shares during the last quarter. Truewealth LLC purchased a new stake in shares of Monsanto in the fourth quarter valued at about $163,000. Finally, Flinton Capital Management LLC raised its holdings in shares of Monsanto by 90.9% in the fourth quarter. Flinton Capital Management LLC now owns 1,764 shares of the basic materials company’s stock valued at $206,000 after buying an additional 840 shares during the last quarter. 73.70% of the stock is owned by institutional investors and hedge funds.
TRADEMARK VIOLATION NOTICE: “Traders Buy Shares of Monsanto (MON) on Weakness” was originally reported by Community Financial News and is owned by of Community Financial News. If you are viewing this news story on another site, it was copied illegally and republished in violation of international trademark & copyright laws. The legal version of this news story can be read at https://www.com-unik.info/2018/02/20/traders-buy-shares-of-monsanto-mon-on-weakness.html.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.